Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase

Toxoplasmosis causes significant morbidity and mortality and yet available medicines are limited by toxicities and hypersensitivity. Since improved medicines are needed urgently, rational approaches were used to identify novel lead compounds effective against Toxoplasma gondii enoyl reductase (TgENR...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tipparaju, Suresh K., Muench, Stephen P., Mui, Ernest J., Ruzheinikov, Sergey N., Lu, Jeffrey Z., Hutson, Samuel L., Kirisits, Michael J., Prigge, Sean T., Roberts, Craig W., Henriquez, Fiona L., Kozikowski, Alan P., Rice, David W., McLeod, Rima L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2932859/
https://ncbi.nlm.nih.gov/pubmed/20698542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9017724
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky